Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Published Online
on March 2, 2009

Circulation. 2009
Published online before print March 2, 2009, doi: 10.1161/CIRCULATIONAHA.108.816546
A more recent version of this article appeared on March 17, 2009
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
119/10/1370    most recent
CIRCULATIONAHA.108.816546v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wald, R. M.
Right arrow Articles by Geva, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wald, R. M.
Right arrow Articles by Geva, T.
Related Collections
Right arrow CT and MRI

Submitted on October 2, 2007
Accepted on January 7, 2009

Effects of Regional Dysfunction and Late Gadolinium Enhancement on Global Right Ventricular Function and Exercise Capacity in Patients With Repaired Tetralogy of Fallot

Rachel M. Wald MD, Idith Haber PhD, Ron Wald MDCM, MPH, Anne Marie Valente MD, Andrew J. Powell MD, and Tal Geva MD*

From the Department of Cardiology (R.M.W., I.H., A.M.V., A.J.P., T.G.), Children's Hospital Boston and Department of Pediatrics, Harvard Medical School, Boston, Mass; and the Department of Medicine (R.W.), University of Toronto, Toronto, Ontario, Canada.

* To whom correspondence should be addressed. E-mail: tal.geva{at}cardio.chboston.org.

Background—The underlying mechanisms that contribute to global right ventricular (RV) dysfunction in patients with repaired tetralogy of Fallot are incompletely understood. We therefore sought to quantify regional RV abnormalities and to determine the relationship of these to global RV function and exercise capacity.

Methods and Results—Clinical and cardiac magnetic resonance data from 62 consecutive patients with repaired tetralogy of Fallot were analyzed (median age at follow-up 23 years [limits 9 to 67 years]). Using cardiac magnetic resonance data, 3D RV endocardial surface models were reconstructed from segmented contours, and a correspondence between end diastole and end systole was computed with a novel algorithm. Regional RV abnormalities were quantified and expressed as segmental ejection fraction, spatial extent of dyskinetic area, displacement of dyskinetic area, and score of extent of late gadolinium enhancement. Regional abnormalities of function and hyperenhancement were greatest in the RV outflow tract (RVOT). These regional RVOT abnormalities correlated with global RV ejection fraction: RVOT ejection fraction r=0.64, P<0.0001; RVOT dyskinetic area r=-0.51, P<0.0001; RVOT displacement of dyskinetic area r=-0.49, P<0.0001; and RVOT late gadolinium enhancement score r=-0.33, P=0.01. Peak oxygen consumption during exercise correlated best with RVOT ejection fraction (r=0.56, P=0.0002) compared with the remainder of the RV (r=0.35, P=0.03). The only cardiac magnetic resonance variable independently predictive of aerobic capacity was RVOT ejection fraction (P=0.02).

Conclusion—A greater extent of regional abnormalities in the RVOT adversely affects global RV function and exercise capacity after tetralogy of Fallot repair. These regional measures may have important implications for patient management, including RVOT reconstruction, at the time of pulmonary valve replacement.


Key words: tetralogy of Fallot • heart defects, congenital • magnetic resonance imaging